Experimental antibody drug shrinks tumors in soft tissue sarcoma trial
An antibody-drug conjugate, a type of drug that targets and enters cancer cells like a Trojan Horse, has shown promising early results across diverse types of soft tissue sarcoma in a phase I trial.
Read original article on The Medical News →